New award for gabapentin capsules with xlcare pharmaceuticals, INC. Period of performance is november 11, 2023 through november 10, 2024 with four one year options.

Active Indefinite Delivery Contract Awarded Last action

Contract number
36E79723D0027
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 99% complete
IDV ceiling
$54,110,891.35
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 7 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs National Acquisition Center awarded a single-award IDIQ to Xlcare Pharmaceuticals Inc. for gabapentin capsules with a ceiling of $54,110,891.35, effective November 11, 2023. Xlcare Pharmaceuticals Inc. is certified as an economically disadvantaged woman-owned small business and minority-owned, small disadvantaged business.

The contract runs from November 11, 2023 through November 10, 2024 with four one-year options. The IDIQ was established to supply gabapentin capsules in multiple package sizes (ranging from 30 to 1000 count bottles across 13 presentations) to meet estimated annual needs exceeding 3 million capsules for the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The primary NAICS code is 325412. The underlying solicitation (36E79723R0023) required offerors to supply products using their own unique NDC number and evaluated proposals without set-aside preference. A modification implementing Executive Order 14398 regarding diversity, equity, and inclusion discrimination has been applied to the contract.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00004 · Modification to implement EO 14398 DEI discrimination. $0
Exercise an Option P00003 · Exercise option year 2 effective 11/11/2025 through 11/10/2026 for gabapentin capsules with xlcare pharmaceuticals, INC. Prices remain unchanged. $0
Exercise an Option P00002 · Exercise option year one effective 11/11/2024 through 11/10/205 for gabapentin capsules with xlcare pharmaceuticals, INC. Prices remain unchanged. $0
Other Administrative Action P00001 · Cost recovery fee and submission of quarterly sales report changes effective 2/9/2024 for gabapentin capsules with xlcare pharmaceuticals, INC. $0
Original award $0

Quick answers

Who was awarded contract 36E79723D0027?

36E79723D0027 was awarded to Xlcare Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on November 11, 2023.

How much is contract 36E79723D0027 worth?

36E79723D0027's own ceiling is $54,110,891.

Who can order from contract 36E79723D0027?

36E79723D0027 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 36E79723D0027 competed?

The extent of competition for 36E79723D0027 was full and open competition. The government received 7 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV